ScholarIQanswers from OpenAlex
The Lancet Oncology
JournalCitation impact & published research
The Lancet Oncology is a journal indexed in ScholarIQ from OpenAlex.
How many works does The Lancet Oncology have?
ScholarIQindexed works
The Lancet Oncology has 12,160 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does The Lancet Oncology have?
ScholarIQcitation count
The Lancet Oncology has 1,059,117 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of The Lancet Oncology?
ScholarIQh-index
The Lancet Oncology has an h-index of 521 in OpenAlex.
What is the article processing charge of The Lancet Oncology?
ScholarIQarticle processing charge
The Lancet Oncology lists an article processing charge of 6,300 USD in OpenAlex.
What is the OpenAlex record for The Lancet Oncology?
ScholarIQopenalex
The OpenAlex for The Lancet Oncology is on the source record.
What are the most-cited papers on The Lancet Oncology?
ScholarIQmost cited works
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon, Florian Strasser, Stefan D. Anker, Ingvar Bosæus, Éduardo Bruera, Robin L. Fainsinger, Aminah Jatoi, Charles L. Loprinzi, Neil Macdonald, Giovanni Mantovani, Mellar P. Davis, Maurizio Muscaritoli, Faith D. Ottery, Lukas Radbruch, Paula Ravasco, Declan Walsh, Andrew Wilcock, Stein Kaasa, Vickie E. Baracos
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang, Wei‐jie Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou, Yi‐Long Wu, Gongyan Chen, Jifeng Feng, Xiao-Qing Liu, Changli Wang, Shucai Zhang, Jie Wang, Songwen Zhou, Shengxiang Ren, Shun Lü, Li Zhang, Chengping Hu, Chunhong Hu, Yi Luo, Lei Chen, Ming Ye, Jianan Huang, Xiuyi Zhi, Yiping Zhang, Qingyu Xiu, Jun Ma, L Zhang, Changxuan You
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. Prado, Jessica Lieffers, Linda J. McCargar, Tony Reiman, Michael B. Sawyer, Lisa Martin, Vickie E. Baracos